India KV Subramaniam, president of Reliance Life Sciences, a research-driven medical biotech with a fully integrated value chain that covers everything from research to manufacturing, comments on the firm’s unique positioning and its efforts to diversify its portfolio. Moving beyond plasma proteins and biosimilars, Reliance looks to expand into vaccines and…
Singapore The latest pharma news from Singapore, including J&J Innovation’s continued investment in Singapore; Evotec’s new Singaporean venture, 65LAB; BeiGene’s cancer drug approval in the country; Novo Nordisk’s acquisition of local biotech KBP Biosciences’ late-stage investigational hypertension drug, and Crown Bioscience/JSR Life Sciences’ new manufacturing facility. Johnson & Johnson Innovation…
Hong Kong As managing director of the CR-CP Life Science Fund, whose shareholders, CR Group and CP Group, are on the Fortune Global 500 List, Da Liu leads investments in life sciences companies globally, especially those in emerging sectors such as RNA therapeutics and cancer screening. In conversation with PharmaBoardroom, Liu discusses…
China A roundup of some of the biggest pharma and biotech news from China including the collaboration between Elektr and Sinopharm; Biocytogen’s partnership with Janssen and deal with Chipscreen Biosciences; China’s first personalised neoantigen-targeted cancer vaccine approval; the final green light for Sino Biopharm’s purchase of F-star, and AstraZeneca’s deal with…
India The latest news from the Indian pharma industry, including WHO’s recommendation not to use cough syrup from Marion Biotech after further deaths, Indegene’s expanded presence in Europe, Sun Pharma’s FDA warning and the lab partnership between Sai Life Sciences and Schrödinger. WHO recommends not using Marion Biotech cough syrups…
Spain Alta Life Sciences is one of Catalonia’s top venture capital investor groups in the biotech sector. Montserrat Vendrell, partner and a pivotal figure in the development of the region’s life sciences ecosystem, explains the VC’s investment strategy, their connection with US-based funds, and the challenges ahead for Catalonia’s bioregion. …
Denmark The Danish Life Science Cluster is Denmark’s new national business cluster for life science technology, established in December 2020 with the goal of strengthening collaboration between the country’s public and private sectors and commercialising more of the discoveries being made in its world-class research universities. The Cluster’s director, Diana Arsovic…
Sweden Invest in Skåne is the official regional business promotion agency for Southern Sweden and provides one-stop investment and export consultancy. Ulrika Ringdahl, managing director, reveals the unique opportunities available in the region’s life sciences industry, explains how the Skåne region managed to overcome the departure of AstraZeneca, and discusses the…
Sweden Some of the key stakeholders in Swedish healthcare and life sciences outline why they feel Sweden’s capital, Stockholm, is a rising star in life sciences innovation. The Stockholm region is one of the most innovative life sciences hubs in the world Irene Svenonius, Region Stockholm Stockholm, a city built…
Sweden Sweden is aiming to become a leading innovation nation in the life sciences, with the creation of a Life Sciences Office showing that the sector is right at the top of the Nordic nation’s political agenda. Today, life science is the only sector for which an official government office…
Sweden The Life Sciences Office Sweden was commissioned in February 2018 and is modelled on the UK’s Office for Life Sciences. Jenni Nordborg, the Office’s director and national coordinator, discusses the future of the life sciences sector in Sweden, including digitalization and collaborations with other Nordic nations. I believe in…
USA Christopher P. Molineaux of Life Sciences Pennsylvania outlines the Keystone State’s rich lineage of pharmaceutical innovation, how the association is building inter-state and international connections, and why Philadelphia is justified in branding itself as the ‘Cellicon Valley’. We are at the epicentre of cell and gene therapy, what we…
See our Cookie Privacy Policy Here